Example: Heart Attack

Clinical Trials Sponsored by Sanquin

Total 46 results

    • NCT04024202
      Recruiting
      Data Registry of Auto Immune Hemolytic Anemia
      Conditions: Autoimmune Hemolytic Anemia
    • NCT03993613
      Recruiting
      Apotransferrin in Patients With β-thalassemia
      Conditions: β-thalassemia Intermedia
    • NCT03899142
      Completed
      Pharmacokinetics of New HepBQuin
      Conditions: Healthy
    • NCT01985373
      Completed
      Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml
      Conditions: Primary Immunodeficiency
    • NCT01797055
      Recruiting
      Apotransferrin in Atransferrinemia
      Conditions: Congenital Atransferrinemia
    • NCT00892112
      Completed
      Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
      Conditions: Myocardial Diseases; Parvovirus B19, Human
    • NCT03539159
      Recruiting
      Assessment of the Mu-Drop System for Serum Eye Drops
      Conditions: Dry Eye Syndrome
    • NCT03288012
      Recruiting
      Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
      Conditions: Alloimmunization; Sickle Cell Disease
    • NCT00522821
      Completed
      Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response
      Conditions: IgG Deficiency; Infections
    • NCT03085290
      Completed
      Allogeneic Versus Autologous Serum Eye Drops
      Conditions: Dry Eye Syndrome
    • NCT02783313
      Completed
      Pathogen Reduction Evaluation & Predictive Analytical Rating Score
      Conditions: Thrombocytopenia
    • NCT00151853
      Completed
      Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery
      Conditions: CPB; Oral Anticoagulant Therapy
    • NCT00151840
      Completed
      Efficacy and Safety of IVIG-L in ITP Patients
      Conditions: Purpura, Thrombocytopenic, Idiopathic
    • NCT00139828
      Completed
      Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
      Conditions: Hemophilia B
    • NCT00138736
      Completed
      Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
      Conditions: MBL-Deficient; Neutropenia
    • NCT00138697
      Completed
      Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
      Conditions: Hypogammaglobulinemia
    • NCT00125541
      Completed
      C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
      Conditions: Angioedema
    • NCT00125151
      Completed
      C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
      Conditions: Angioedema
    • NCT00119431
      Completed
      Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
      Conditions: Hereditary Angioedema Type I; Angioneurotic Edema
    • NCT04626661
      Recruiting
      Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study)
      Conditions: Mitochondrial Oxygenation Measurement; Measurement Error; Healthy
    • NCT01616329
      Unknown status
      R-FACT Study:Risk Factors for Alloimmunization After Red Blood Cell Transfusions
      Conditions: Hemolysis
    • NCT03842722
      Recruiting
      Insufficient Oxygenation in Septic Patients
      Conditions: Sepsis; Critical Care; Mitochondria; Oxygen; Fluid Therapy
    • NCT01398644
      Unknown status
      Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
      Conditions: Hereditary Hemochromatosis
    • NCT03505086
      Recruiting
      Bleeding In Thrombocytopenia Explained
      Conditions: Hematologic Neoplasms; Bleeding; Hemorrhage; Platelet Transfusion
    • NCT03110887
      Completed
      Monitoring Outcome in Neonatal Thrombocytopenia
      Conditions: Neonatal Thrombocytopenia; Intraventricular Hemorrhage; Platelet Transfusion
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations